癌症生物学与医学（英文版）2025，Vol.22Issue(2)：83-92,10.DOI:10.20892/j.issn.2095-3941.2024.0486
Antibody-drug conjugates in breast cancer:advances and prospects
Antibody-drug conjugates in breast cancer:advances and prospects
Zhiqiang Shi 1Yongjin Lu 2Qiuchen Zhao 3Yongsheng Wang 4Pengfei Qiu4
作者信息
- 1. Breast Cancer Center,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250117,China||Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Tianjin 300202,China
- 2. Breast Cancer Center,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250117,China||Shandong First Medical University(Shandong Academy of Medical Sciences),Jinan 271016,China
- 3. Cancer Research UK Cambridge Centre PhD Programme,University of Cambridge,Cambridge CB2 0XZ,UK
- 4. Breast Cancer Center,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250117,China
- 折叠
引用本文复制引用
Zhiqiang Shi,Yongjin Lu,Qiuchen Zhao,Yongsheng Wang,Pengfei Qiu..Antibody-drug conjugates in breast cancer:advances and prospects[J].癌症生物学与医学（英文版）,2025,22(2):83-92,10.基金项目
This work was supported by grants from the National Natural Science Foundation of China(Grant No.81672638). （Grant No.81672638）
